CI 911,
CI-911,
dihydro-1H-pyrrolizine-3,5-(2H,6H)-dione,
rolziracetam,
Rolziracetam,
3,5-Dioxopyrrolizidine,
Dihydro-1H-pyrrolizine-3,5(2H,6H)-dione,
18356-28-0,
UNII-RES9I0LGG5,
Rolziracetam [INN:BAN],
Rolziracetamum [INN-Latin],
CI-911,
CI 911,
NSC122751,
RES9I0LGG5,
NSC 122751,
BRN 0121236,
IEZDOKQWPWZVQF-UHFFFAOYSA-N,
1H-Pyrrolizine-3,5(2H,6H)-dione, dihydro-,
2,6,7,8-tetrahydro-1H-pyrrolizine-3,5-dione,
Rolziracetamum,
Pyrrolizidine-3,5-dione,
AC1L2H0D,
CHEMBL51396,
3H-Pyrrolizine-3,5(2H)-dione, tetrahydro- (6CI),
SCHEMBL1159965,
ZINC2037,
CTK7H3695,
DTXSID80171444,
Tetrahydro-pyrrolizine-3,5-dione,
hexahydro-1H-pyrrolizine-3,5-dione,
FCH842503,
MFCD00867785,
AKOS006272848,
NSC-122751,
ACM18356280,
HY-119602,
LS-139099,
CS-0070039,
dihydro 1H-pyrrolizine-3,5(2H, 6H) dione,
dihydro-1H-pyrrolizine-3,5(2H, 6H)-dione,
dihydro-1H-pyrrolizine-3,5-(2H,6H)-dione,
3H-Pyrrolizine-3,5(2H)-dione, tetrahydro-,
dihydro 1H-pyrrolizine-3,5 (2H, 6H) dione,
2,6,7,8-tetrahydro-1''H''-pyrrolizine-3,5-dione,
DIHYDRO-1H-PYRROLO[1,2-A]PYRROLE-3,5(2H,6H)-DIONE,
Rolziracetam [BAN:INN],
C7-H9-N-O2,
CID71893,
5-21-10-00069 (Beilstein Handbook Reference),